Atlas Venture Associates XI, 10% Owner: Xilio Therapeutics XLO Sell · Filed 24/01/16

Trade details

Type: Insider sale
Amount: $1,362.42
Shares · price: 1,566 sh · $0.87 a share
Held after: 2,021,836 sh
Stock: Xilio Therapeutics XLO
Person: Atlas Venture Associates XI10% Owner
Trade date: 24/01/11
Filed: 24/01/16
Days to filing: 5 days

Sold 0.1% of holdings

Share of holding sold: 0.1%

Xilio Therapeutics trades, last 26 weeks

What else happened in Xilio Therapeutics around then

Filed or reported within 30 days of the trade day · 23/12/12~24/02/10

Atlas Venture Associates XI's recent trades

Atlas Venture Associates XI10% Owner
BuySionna Therapeutics
Buy
Sionna Therapeutics
SION
$1.1M
60,000 sh
$1.1M
Filed 25/02/10
Traded 25/02/10
Atlas Venture Associates XI10% Owner
Sell10b5-1 planDyne Therapeutics
Sell10b5-1 plan
Dyne Therapeutics
DYN
$6.7M
272,923 sh
$6.7M
Filed 24/02/28
Traded 24/02/27
Atlas Venture Associates XI10% Owner
Sell10b5-1 planDyne Therapeutics
Sell10b5-1 plan
Dyne Therapeutics
DYN
$3.8M
152,244 sh
$3.8M
Filed 24/02/28
Traded 24/02/28
Atlas Venture Associates XI10% Owner
Sell10b5-1 planDyne Therapeutics
Sell10b5-1 plan
Dyne Therapeutics
DYN
$3.2M
136,312 sh
$3.2M
Filed 24/02/28
Traded 24/02/26
Atlas Venture Associates XI10% Owner
Sell10b5-1 planDyne Therapeutics
Sell10b5-1 plan
Dyne Therapeutics
DYN
$1.6M
64,783 sh
$1.6M
Filed 24/02/28
Traded 24/02/26